Press release
Inotropic Agents Market 2023 : Industry Insights, Growing Trends And Outlook 2032 | Pfizer Inc., GSK PLC., Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH
Inotropic Agents Market Research
The Business Research Company's Inotropic Agents Global Market Report 2023 identifies surge in the prevalence of cardiovascular diseases as the major driver for the Inotropic Agents market's growth in the forecast period. Cardiovascular diseases (CVDs) refer to diseases of the vascular system and heart functioning. Inotropic agents are used in the treatment of cardiovascular diseases to improve the contractility and function of the heart, tackle cardiac shock, and slow the heart rate as they help the heart contract more powerfully, thereby increasing blood flow. So this helps boost the inotropic agent market.
The global inotropic agents market size is expected to grow from $2.10 billion in 2022 to $2.32 billion in 2023 at a compound annual growth rate (CAGR) of 10.88%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global inotropic agents market size is expected to reach $3.56 billion in 2027 at a CAGR of 11.24%.
Download Free Sample Of Inotropic Agents Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=10711&type=smp
Major competitors in the Inotropic Agents market are Pfizer Inc., GSK PLC., Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH, AstraZeneca PLC., Johnson & Johnson, Bayer AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Cipla Ltd., Eli Lilly And Company, Sanofi S.A., Baxter International Inc., Hikma Pharmaceuticals PLC., Sun Pharmaceuticals Industries Ltd. and Cadila Pharmaceuticals Ltd.
A key trend in the Inotropic Agents market includes drug approval. Major companies in the market are developing innovative new products and drugs to sustain their position in the market. For instance, in April 2022, Bristol-Myers Squibb., a US-based pharmaceutical developer and manufacturer, received regulatory approval for Camzyos™ (mavacamten) from the U.S. Food and Drug Administration (FDA), a US-based national public health agency and regulator. It is used in the treatment of class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. This medication works by inhibiting the excessive contraction of the heart muscle.
Read More On The Global Inotropic Agents Market Report Here:
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
The Inotropic Agents market is segmented -
By Type: Positive Inotropic Drugs, Negative Inotropic Drugs, Other Types
By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
By Indication: Heart Attack, Heart Failure, Angina, Arrhythmia, Other Indications
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
By End User: Hospital, Homecare, Specialty Centers, Other End Users
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Inotropic Agents market.
The Business Research Company's "Global Inotropic Agents Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Inotropic Agents Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10711
The Table Of Content For The Inotropic Agents Market Include:
1. Executive Summary
2. Inotropic Agents Market Characteristics
3. Inotropic Agents Market Trends And Strategies
4. Inotropic Agents Market - Macro Economic Scenario
5. Inotropic Agents Market Size And Growth
……
26. Africa Inotropic Agents Market
27. Inotropic Agents Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Inotropic Agents Market
29. Inotropic Agents Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inotropic Agents Market 2023 : Industry Insights, Growing Trends And Outlook 2032 | Pfizer Inc., GSK PLC., Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH here
News-ID: 3162231 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Inotropic
Top Trends Transforming the Inotropic Agents Market Landscape in 2025: Bristol-M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Inotropic Agents Industry Market Size Be by 2025?
Over the previous years, the inotropic agents market has seen quick expansion. Predictions for growth anticipate it to rise from $2.56 billion in 2024 to $2.82 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%.…
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Inotropic Agents Market Through 2025?
The market size for inotropic agents has expanded significantly in the previous years. The market is expected to increase from $2.56 billion in 2024 to $2.84 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 13 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market Driv …
What market dynamics are playing a key role in accelerating the growth of the inotropic agents market?
The increase in occurrences of cardiovascular diseases is fueling the growth of the inotropic agent market. Cardiovascular diseases, which pertain to disorders of the heart and vascular system, are often treated with inotropic agents. These substances enhance the heart's contractility, help manage cardiac shock, and slow down the heart rate by assisting the heart…
Inotropic Agents Market: Exploring Size, Growth Rate, Drivers, and Trends
Expanding Scope and Implications of Inotropic Agents in Cardiac Health
What Is The Projected Market Size Of The Global Inotropic Agents Market And Its Growth Rate?
The inotropic agents market has seen a significant growth, driven by the medical advancements and the rising awareness of cardiac health.
• Market size in 2024: $2.56 billion
• Market size in 2025: $2.84 billion (11.1% CAGR)
• Expected Market size in 2029: $4.52 billion (12.3% CAGR)
The key factors…
